Prevention of in-stent neointimal proliferation by Pioglitazone Study
Not Applicable
Completed
- Conditions
- Type 2 diabetic patients with ischemic heart disease
- Registration Number
- JPRN-UMIN000000485
- Lead Sponsor
- Bell Land General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1).Severe liver or renal insufficiency(2).TIMI-flow grade <= 2 (3).Cardiogenic shock or congestive heart failure (4).Contraindication to antiplatelet therapy (5).Patient with gastrointestinal bleeding or transient ischemic attack (6).Ineligible for CABG (7). Ineligible for percutaneous coronary intervention
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Angiographical restenosis and target lesion revascularization at 6 months follow-up
- Secondary Outcome Measures
Name Time Method eointimal volume assessed by intravascular ultrasound at 6months follow-up